14-92011029-A-T
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4
The NM_004239.4(TRIP11):c.1271T>A(p.Ile424Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,836 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I424S) has been classified as Uncertain significance.
Frequency
Consequence
NM_004239.4 missense
Scores
Clinical Significance
Conservation
Publications
- achondrogenesis type IAInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Laboratory for Molecular Medicine
 - TRIP11-related skeletal dysplasiaInheritance: AR Classification: DEFINITIVE Submitted by: Ambry Genetics
 
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  Cov.: 30 
GnomAD4 exome  AF:  6.84e-7  AC: 1AN: 1461836Hom.:  0  Cov.: 31 AF XY:  0.00  AC XY: 0AN XY: 727222 show subpopulations 
GnomAD4 genome  Cov.: 30 
ClinVar
Not reported inComputational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at